Director/PDMR Shareholding
RNS Number : 0348XCentrica PLC30 September 2026
Centrica plc (the 'Company')
30 September 2026
Notification of Transactions of Directors
The Company was notified by Computershare Investor Services PLC, the administrators of the Company's Restricted Share Plan (the 'Plan'), that Centrica plc ordinary shares of 6 14/81 pence ('Shares') have been acquired through reinvestment of the Company's 2026 interim dividend of 2.00 pence per share paid on 22 September 2026.
The following notification, made pursuant to Article 19 of the Market Abuse Regulation, provides further details.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Russell O'Brien
2
Reason for the notification
a)
Position/status
Executive Director
b)
Initial notification/Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Centrica plc
b)
LEI
E26EDV109X6EEPBKVH76
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial
instrument, type of instrument
Identification code
Ordinary shares of 6 14/81 pence
GB00B033F229
b)
Nature of the transaction
Acquisition of Shares on behalf of a PDMR by Computershare through reinvested dividends
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£1.4928
5,121.11738
d)
Aggregated information
Aggregated volume
- Price
- Total
5,121.11738 Shares
£1.493 per Share
£7,644.80
e)
Date of the transaction
22 September 2026
f)
Place of the transaction
London Stock Exchange (XLON)
Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GDRegistered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHWPURCBUPQGWU